Pandemic Influenza Vaccine
Pandemic Influenza Vaccine - most related articles:
-
Universal Influenza vaccine holds promise - 11.1
-
H1N1 flu vaccines to be used in 2010 influenza season - 10.8
-
Novartis inaugurates influenza vaccine manufacturing facility - 10.4
-
H1N1 flu vaccine donations for developing world - 10.1
-
Sanofi Pasteur's New Influenza Vaccine Plant, US - 9.8
-
Human vaccine against bird flu soon - 9.2
-
Canada funding H1N1 flu virus research to protect Canadians - 8.9
-
H1N1 vaccine Focetria receives positive opinion from CHMP - 8.9
-
New bird flu vaccine may give long-term defense - 8.7
-
Insect cells provide the key to alternative swine flu vaccination - 8.4
Pandemic Influenza Vaccine articles
Safety of pandemic H1N1 vaccines monitored by WHOWHO estimates that around 80 million doses of pandemic vaccine have been distributed and around 65 million people have been vaccinated. National immunization campaigns began in Australia and the People's Republic of China in late September.
WHO reviewed pandemic vaccine policies and strategiesThe Strategic Advisory Group of Experts (SAGE) on Immunization, which advises WHO on policies and strategies for vaccines and immunization, devoted a session of its 27–29 October meeting to pandemic influenza vaccines.
H1N1 vaccine Focetria receives positive opinion from CHMPNovartis announced that Focetria, the Novartis Influenza A(H1N1) 2009 monovalent vaccine, has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA).
H1N1 flu vaccines to be used in 2010 influenza seasonPandemic influenza A H1N1 viruses are becoming much more common than the current seasonal influenza. WHO health experts have recommended that vaccines for use in the 2010 influenza season (southern hemisphere winter) contain the following:
Canada funding H1N1 flu virus research to protect CanadiansThe Honourable Leona Aglukkaq, Minister of Health, is pleased to announce another measure to address the H1N1 flu virus. The Government of Canada will fund a national influenza research network focused on pandemic vaccine evaluation.
Sanofi Pasteur's New Influenza Vaccine Plant, USSanofi Pasteur, the vaccines division of sanofi-aventis Group (Euronext: SAN) (NYSE: SNY), announced that the U.S. Food and Drug Administration (FDA) has licensed its new influenza vaccine manufacturing facility.
Universal Influenza vaccine holds promiseAn influenza vaccine that protects against death and serious complications from different strains of flu is a little closer to reality, Saint Louis University vaccine researchers have found.
2 doses of flu vaccine needed against bird flu pandemicAn international study led by University of Leicester researchers has determined that vaccination will be the best way to protect people in the event of the next influenza pandemic – but that each person would need two doses.
8 Pandemic Influenza Vaccine articles listed above.
Mission
Health Newstrack is dedicated to serve recent and updated health & medical research, events/news, views/reviews to its subscribers and free access to general public, health & medical professionals, and other health seekers worldwide online with a user-friendly system.